IGHE and Increased total eosinophil count: The ability of omalizumab to reduce sputum eosinophilia and increase of the dose of methacholine required to induce a fall in FEV1 shows that in addition to inhibiting free IgE, omalizumab also has an effect on inflammatory cells [22].